Prostate cancer may not show symptoms in its early stages, making early detection challenging. However, when symptoms do appear, the disease often has advanced. In early-stage prostate cancer, typical symptoms may not be present, but certain complaints can indicate the disease’s onset.
These symptoms include difficulty urinating (burning sensation, difficulty), and the presence of blood in urine or semen. These signs may indicate that the prostate gland is enlarging and putting pressure on the urinary tract. Additionally, weak or interrupted urine flow, frequent urination, especially at night, and the need to urinate urgently can also be symptoms of prostate cancer.
In metastatic prostate cancer, cancer cells can spread outside the prostate gland. This typically involves spreading to the bones, especially the spine, hips, or pelvis. In this case, patients may experience bone pain, weakness, and even fractures.
Diagnosing prostate cancer typically involves a digital rectal exam and measuring the total PSA (Prostate-Specific Antigen) level. However, routine PSA testing in the general population is thought to have limited impact on prostate cancer survival. Nevertheless, PSA testing may be considered in specific circumstances.
During the digital rectal exam, irregularities, asymmetric growth, or hardness in the prostate gland may necessitate a prostate biopsy. It’s important to complement this exam with a measurement of the total PSA level.
Total PSA measures the level of PSA, a protein enzyme produced primarily by the prostate gland, in the blood. However, an increase in PSA levels can be associated with conditions other than prostate cancer.
Multiparametric prostate MRI (Magnetic Resonance Imaging) can be more effective in detecting cancer, especially when cancerous tissue is large and severe. However, this method is not a standalone diagnostic tool and should be used in conjunction with other tests.
MRI Fusion Prostate Biopsy combines multiparametric prostate MRI with biopsy techniques to sample tissue from suspected cancerous areas. This approach can improve the accuracy of cancer diagnosis and aid in determining treatment options.
Treatment for prostate cancer is tailored based on factors such as age, overall health, disease stage, and other considerations. Treatment options include active surveillance, surgery, radiotherapy, IRE (NanoKnife), hormone therapy, and chemotherapy. The most appropriate treatment plan for each patient should be determined based on their individual circumstances.
Feel free to ask us any questions you have about prostate cancer or request advice related to your concerns. You can reach us through the contact form on our website or by calling us at +90 544 181 3535.
